.4» FINAL DIAGNOSIS:

PART 1: WHT, NEEDLE LOCALIZED SEGMENTAL MASTECTOMY —
A. INVASIVE DUCTAL CARCINOMA, 2.0 CM (GROSS), NOTTINGHAM GRADE 1 (COMBINED NOTTINGHAM
SCORE 419: ULE FORMATION 1/3, NUCLEAR PLEOMORPHISM 213, MITOTIC ACTIVITY 1/3).
DUCTAL CARCINOMA IN SITU (DClS), NUCLEAR GRADE 2, CRIBRIFORM TYPE, CONSTITUTES
APPROXIMATELY 5% OF THE TUMOR VOLUME AND IS ADMIXED WITH THE INVASIVE COMPONENT.
LYMPHOVASCULAR SPACE INVASION IS NOT IDENTIFIED.
MARGINS FREE, CLOSEST ANTERIORISUPERIOR WITHIN 0.6 CM.
DUCTAL EPITHELIAL HYPERPLASIA.
FIBROCYSTIC CHANGES.
SCLEROSING ADENOSIS.
COLUMNAR CELL CHANGE.
FIBROADENOMATOID NODULES.
SKIN IS NEGATIVE FOR TUMOR.

. BIOPSY SITE CHANGaEg.‘ I m:
. ’ [1 | ' l- " I , w. v .
PART 2' AI: ngxgacﬁcincmom (0.4 CM.) INVOLVES ONE OF TWO LYMPH NODES (112) (see comment).

B. EXTRACAPSULAR EXTENSION IS IDENTIFIED, 0.1 CM X 0.07 CM.

F”

xarapwmpp

: YMPH NODE, RIGHT, SENTINEL #2, BIOPSY -
PART 3 AI: METASTATIC CARCINOMA INVOLVES ONE LYMPH NODE
B. EXTRACAPSULAR EXTENSION IS NOT IDENTIFIED.
PART 4: LYMPH NODE, mun r, acn r mm. ms, ISIUPSY —
ONE LYMPH NODE, NEGATIVE FOR METASTATIC CARCINOMA (0I1) (see comment).

(1/1) (see comment).

PART 5: BREAST, RIGHT, NEW LATERAL MARGIN, EXCISION —
A. RADIAL SCAR.
B. FIBROCYSTIC CHANGES.
C. SCLEROSING ADENOSIS.
D. DUCTAL EPITHELIAL HYPERPLASIA.
E. COLUMNAR CELL CHANGE WITH ASSOCIATED CALCIFICATIONS.
F. FAT NECROSIS.
SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST

LATERALITY: Right

PROCEDURE: Segmental

LOCATION: Not speciﬁed

SIZE OF TUMOR: Maximum dimension invasive component: 2 cm

MULTICENTRICITYIMULTIFOCALITY OF INVASIVE FOCI:

TUMOR AGGREGATE SIZE:
TUMOR TYPE (invasive component):

NOTTINGHAM SCORE:

ANGIOLYMPHATIC INVASION:

DERMAL LYMPHATIC INVASION:
CALCIFICATION:

TUMOR TYPE, IN SITU:

Yes
Sum of the sizes of multiple invasive tumors: 2.5 cm

Ductal adenocarcinoma. NOS
Nuclear grade: 2

Tubule formation: 1

Mitotic activity score: 1

Total Nottingham score: 4
Nottingham grade (1, 2. 3): 1
No

No

Yes, benign zones

Yes, malignant zones
Cribrifonn

DClS admixed with invasive carcinoma

Percent of tumor occupied by in situ component: 5 %

/CA «J ’3
(”whim Who/71m; elm/11,”! VFW/3
£175, a W #1.! 650.9 3/13/// A,

SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT:

No
SURG MARGINS INVOLVED BY IN SITU COMPONENT:

LYMPH NODES POSITIVE:
LYMPH NODES EXAMINED:

METHOD(S) OF LYMPH NODE EXAMINATION:

SENTINEL NODE METASTASIS:
SIZE OF NODAL METASTASES:

UUID:DFB211sr-3ec7-raeE-Asac-casarszega1r
TCGA-BH—AOEI—elA-PR Redacted

WMMWMWWWWW
IWMWIWWWImmmmmmmmmmm
:yEskaKeEMnsmki “HIM“HIHMNWHHMHHWMIMHHMHW

Diameter of largest lymph node metastasis: 4 mm

No
2
4

LYMPH NODE METASTASIS(-ES) WITH EXTRACAPSULAR EXTENSION:

T STAGE, PATHOLOGIC:

N STAGE, PATHOLOGIC:

M STAGE, PATHOLOGIC:
ESTROGEN RECEPTORS:
PROGESTERONE RECEPTORS:
HERZINEU:

 
      
   

   

 
 

Yes
PT1c mm
pN1 DIIEHOSIS Oiwespnnzy "2pm” -‘
' Turner in: .5
pr IIIIIITA‘AWDisuepIncy
FOSIIIVe Prior Malignancy Hisr9_r_y
I I Dual/Syrrclvouous Prim-r
posmve ' OWISICIICIII;
zero or 1+ Reviewerlnitiais

